NYSE$STVN
Stevanato Group S.p.A. · Q2 2026 earnings
Q2 2026 earnings · · Before market open · Investor relations
Briefing
Stevanato Group reported 8% revenue growth to €302.0 million for Q2 2026, with improved margins and updated full-year guidance.
Stevanato Group S.p.A. delivered solid Q2 2026 results with revenue up 8% year-over-year to €302.0 million, driven by 9% growth in the Biopharmaceutical and Diagnostic Solutions segment. High-value solutions reached 45% of revenue. Adjusted EBITDA margin expanded 280 basis points to 26.0%, while the company completed the divestiture of Balda C. Brewer and updated its 2026 guidance upward on organic growth and currency.
- Revenue increased 8% to €302.0 million; high-value solutions revenue grew 16% to €135.9 million (45% of total).
- Gross profit margin rose 60 bps to 28.7%; adjusted EBITDA margin improved 280 bps to 26.0%.
- Adjusted diluted EPS rose to €0.14 from €0.11; reported diluted EPS €0.08 after €12.2M divestiture costs.
- Updated FY2026 guidance: revenue €1.260B–€1.280B, adjusted EBITDA €335.0M–€345.2M, adjusted EPS €0.60–€0.62.
Headline financials
Revenue & EPS history
Stevanato Group · Revenue · Quarterly
€348M
Revenue by segment
Stevanato Group · €302M total across 2 segments · Q2 2026
- Biopharmaceutical and Diagnostic Solutions€266M—88.1%
- Engineering€35.8M—11.9%
Forward guidance
Updated FY2026 guidance reflecting divestiture, better currency, and higher organic growth.
Tailwinds
- Revenue range narrowed to €1.260B–€1.280B.
- Adjusted EBITDA €335.0M–€345.2M.
- Adjusted diluted EPS narrowed to €0.60–€0.62.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports
+1.4%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+3.0%
Avg return
30 days after
58%
11 / 19 earnings
Positive
+22.3%
Q2 2021
Best reaction
-18.9%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | — | — | — | |
| Q4 2025 | +10.0% | +1.9% | -10.3% | |
| Q3 2025 | -1.7% | -3.3% | -11.6% | |
| Q2 2025 | -9.6% | -7.6% | -9.9% | |
| Q1 2025 | +2.9% | +12.0% | +8.9% | |
| Q4 2024 | +8.6% | +8.8% | +10.5% | |
| Q3 2024 | +16.4% | +12.4% | +3.9% | |
| Q2 2024 | +4.4% | +8.5% | +13.8% | |
| Q1 2024 | -18.9% | -20.7% | -30.8% | |
| Q4 2023 | -11.3% | -14.1% | -12.4% | |
| Q3 2023 | -5.9% | -2.5% | -3.5% | |
| Q2 2023 | +2.5% | +5.6% | +6.3% | |
| Q1 2023 | -3.3% | -1.5% | +2.6% | |
| Q4 2022 | +13.7% | +5.2% | +16.0% | |
| Q3 2022 | +0.4% | +9.1% | +18.0% | |
| Q2 2022 | +4.6% | -3.4% | -5.9% | |
| Q1 2022 | +0.7% | +8.7% | +11.2% | |
| Q4 2021 | -1.4% | -4.2% | +21.9% | |
| Q3 2021 | -8.7% | -11.2% | -4.8% | |
| Q2 2021 | +22.3% | +27.0% | +33.8% | |
| Q1 2021 | — | — | — | |
| Q4 2020 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro